Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol

Introduction Major depression is a highly prevalent pathology that is currently the second most common cause of disease-induced disability in our society. The onset and continuation of depression may be related to a wide variety of biological and psychosocial factors, many of which are linked to dif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alejandra Aguilar-Latorre, Capilla Navarro, Bárbara Oliván-Blázquez, Elena Gervilla, Rosa Magallón Botaya, Catalina Calafat-Villalonga, Mauro García-Toro, Santiago Boira, María Jesús Serrano-Ripoll
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2020
Materias:
R
Acceso en línea:https://doaj.org/article/b8727a6bd4f3475d8e558823d233af8c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8727a6bd4f3475d8e558823d233af8c
record_format dspace
spelling oai:doaj.org-article:b8727a6bd4f3475d8e558823d233af8c2021-11-18T02:30:07ZEffectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol10.1136/bmjopen-2020-0384572044-6055https://doaj.org/article/b8727a6bd4f3475d8e558823d233af8c2020-12-01T00:00:00Zhttps://bmjopen.bmj.com/content/10/12/e038457.fullhttps://doaj.org/toc/2044-6055Introduction Major depression is a highly prevalent pathology that is currently the second most common cause of disease-induced disability in our society. The onset and continuation of depression may be related to a wide variety of biological and psychosocial factors, many of which are linked to different lifestyle aspects. Therefore, health systems must design and implement health promotion and lifestyle modification programmes (LMPs), taking into account personal factors and facilitators. The main objective of this protocol is to analyse the clinical effectiveness, cost-effectiveness and cost utility of an LMP and an LMP with information and communication technologies (ICTs) as adjunctive treatment for depression in primary care patients. The secondary objectives are to analyse the clinical effectiveness in the subgroup that presents comorbidity and to analyse the correlation between personal factors on health behaviour and lifestyle patterns.Methods and analysis A randomised, multicenter pragmatic clinical trial with three parallel groups consisting of primary healthcare patients suffering from subclinical, mild or moderate depression. The following interventions will be used: (1) Usual antidepressant treatment with psychological advice and/or psychotropic drugs prescribed by the general practitioner (treatment as usual (TAU)). (2) TAU+LMP. A programme to be imparted in six weekly 90-minute group sessions, intended to improve the following aspects: behavioural activation+daily physical activity+adherence to the Mediterranean diet pattern+sleep hygiene+careful exposure to sunlight. (3) TAU+LMP+ICTs: healthy lifestyle recommendations (TAU+LMP)+monitoring using ICTs (a wearable smartwatch). The primary outcome will be the depressive symptomatology and the secondary outcomes will be the quality of life, the use of health and social resources, personal factors on health behaviour, social support, lifestyle patterns and chronic comorbid pathology. Data will be collected before and after the intervention, with 6-month and 12-month follow-ups.Ethics and dissemination This study has been approved by the Clinical Research Ethics Committee of Aragón (approval number: C.P.-C.I. PI18/286) and the Research Ethics Committee of the Balearic Islands (IB3950/19 PI). Data distribution will be anonymous. Results will be disseminated via conferences and papers published in peer-reviewed, open-access journals.Trial registration number ClinicalTrials.gov Registry (NCT03951350).Alejandra Aguilar-LatorreCapilla NavarroBárbara Oliván-BlázquezElena GervillaRosa Magallón BotayaCatalina Calafat-VillalongaMauro García-ToroSantiago BoiraMaría Jesús Serrano-RipollBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 10, Iss 12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Alejandra Aguilar-Latorre
Capilla Navarro
Bárbara Oliván-Blázquez
Elena Gervilla
Rosa Magallón Botaya
Catalina Calafat-Villalonga
Mauro García-Toro
Santiago Boira
María Jesús Serrano-Ripoll
Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
description Introduction Major depression is a highly prevalent pathology that is currently the second most common cause of disease-induced disability in our society. The onset and continuation of depression may be related to a wide variety of biological and psychosocial factors, many of which are linked to different lifestyle aspects. Therefore, health systems must design and implement health promotion and lifestyle modification programmes (LMPs), taking into account personal factors and facilitators. The main objective of this protocol is to analyse the clinical effectiveness, cost-effectiveness and cost utility of an LMP and an LMP with information and communication technologies (ICTs) as adjunctive treatment for depression in primary care patients. The secondary objectives are to analyse the clinical effectiveness in the subgroup that presents comorbidity and to analyse the correlation between personal factors on health behaviour and lifestyle patterns.Methods and analysis A randomised, multicenter pragmatic clinical trial with three parallel groups consisting of primary healthcare patients suffering from subclinical, mild or moderate depression. The following interventions will be used: (1) Usual antidepressant treatment with psychological advice and/or psychotropic drugs prescribed by the general practitioner (treatment as usual (TAU)). (2) TAU+LMP. A programme to be imparted in six weekly 90-minute group sessions, intended to improve the following aspects: behavioural activation+daily physical activity+adherence to the Mediterranean diet pattern+sleep hygiene+careful exposure to sunlight. (3) TAU+LMP+ICTs: healthy lifestyle recommendations (TAU+LMP)+monitoring using ICTs (a wearable smartwatch). The primary outcome will be the depressive symptomatology and the secondary outcomes will be the quality of life, the use of health and social resources, personal factors on health behaviour, social support, lifestyle patterns and chronic comorbid pathology. Data will be collected before and after the intervention, with 6-month and 12-month follow-ups.Ethics and dissemination This study has been approved by the Clinical Research Ethics Committee of Aragón (approval number: C.P.-C.I. PI18/286) and the Research Ethics Committee of the Balearic Islands (IB3950/19 PI). Data distribution will be anonymous. Results will be disseminated via conferences and papers published in peer-reviewed, open-access journals.Trial registration number ClinicalTrials.gov Registry (NCT03951350).
format article
author Alejandra Aguilar-Latorre
Capilla Navarro
Bárbara Oliván-Blázquez
Elena Gervilla
Rosa Magallón Botaya
Catalina Calafat-Villalonga
Mauro García-Toro
Santiago Boira
María Jesús Serrano-Ripoll
author_facet Alejandra Aguilar-Latorre
Capilla Navarro
Bárbara Oliván-Blázquez
Elena Gervilla
Rosa Magallón Botaya
Catalina Calafat-Villalonga
Mauro García-Toro
Santiago Boira
María Jesús Serrano-Ripoll
author_sort Alejandra Aguilar-Latorre
title Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
title_short Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
title_full Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
title_fullStr Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
title_full_unstemmed Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
title_sort effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
publisher BMJ Publishing Group
publishDate 2020
url https://doaj.org/article/b8727a6bd4f3475d8e558823d233af8c
work_keys_str_mv AT alejandraaguilarlatorre effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT capillanavarro effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT barbaraolivanblazquez effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT elenagervilla effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT rosamagallonbotaya effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT catalinacalafatvillalonga effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT maurogarciatoro effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT santiagoboira effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
AT mariajesusserranoripoll effectivenessandcosteffectivenessofalifestylemodificationprogrammeinthepreventionandtreatmentofsubclinicalmildandmoderatedepressioninprimarycarearandomisedclinicaltrialprotocol
_version_ 1718425187573039104